04/08/2026
【A-Share Rally Gains Momentum as CSI STAR&CHINEXT 50 Index closed up 5.44% 】
CSI STAR&CHINEXT 50 Index closed up 5.44% while Index closed up 5.64% today, with around 70% of its 100 constituent stocks trading higher. 📈🚀
China's three leading optical module companies — Eoptolink Technology, Zhongji Innolight, and TFC Optical Communication — each gained more than 10% at their intraday highs, while other technology names also posted strong gains.
Chen Guo, Deputy Director of the Research Institute and Chief Strategy Officer at Orient Securities, remains optimistic on the A-share market outlook, citing increasingly clear bottom signals in the aspects of policy, liquidity, domestic demand and sentiment. Since July, market support has come from state-owned capital platforms increasing holdings, continued equity ETF inflows, rising share buybacks by listed companies, and a moderation in major shareholder selling.
Against this backdrop, China’s technology and innovation-driven sectors may continue to present structural opportunities. For investors looking to capture potential upside in China’s A-share market, the CSOP CSI STAR and CHINEXT 50 Index ETF (Stock Code: ) provides diversified exposure to leading companies listed on the STAR Market and ChiNext Board, helping investors participate in China’s long-term innovation growth story. 💡
Source: CN Stock, Winds as of 4 August 2026
Learn More 👉https://www.csopasset.com/sg/en/products/sg-csi50/etf.php
Disclaimer
The collective investment scheme, as mentioned in this content, is registered under section 286 of the Securities and Futures Act (Cap. 289) of Singapore (the “SFA”). This content shall not be regarded as an offer or solicitation of business.
CSOP Asset Management Pte. Ltd. (“CSOP”) which prepared this content believes that information in this content is based upon sources that are believed to be accurate, complete, and reliable. However, CSOP does not warrant the accuracy and completeness of the information and shall not be liable to the recipient or controlling shareholders of the recipient resulting from its use.
Advice should be sought from a financial adviser regarding the suitability of the investment and/or investment product before making an investment. Investment involves risk. The value of investments, and the income from them, can go down as well as up and an investor may get back less than the amount invested. Past performance is not necessarily indicative of future performance. Investor should read the prospectus and product highlights sheet, which can be obtained on CSOP website or authorized participating dealers, before deciding whether to invest. This content has not been reviewed by the Monetary Authority of Singapore.
SCY
All rights in the Index vest in China Securities Index Company (“CSI”). CSI does not make any warranties, express or implied, regarding the accuracy or completeness of any data related to the Index. CSI is not liable to any person for any error of the Index (whether due to negligence or otherwise), nor shall it be under any obligation to advise any person of any error therein. The Product based on the Index is in no way sponsored, endorsed, sold or promoted by CSI and CSI shall not have any liability with respect thereto.